A detailed history of Prossimo Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Prossimo Advisors, LLC holds 2,087 shares of VRTX stock, worth $1.03 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
2,087
Previous 1,628 28.19%
Holding current value
$1.03 Million
Previous $763,000 27.26%
% of portfolio
0.71%
Previous 0.69%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$460.0 - $505.78 $211,140 - $232,153
459 Added 28.19%
2,087 $971,000
Q2 2024

Jul 22, 2024

BUY
$392.81 - $485.53 $5,892 - $7,282
15 Added 0.93%
1,628 $763,000
Q1 2024

May 03, 2024

BUY
$407.69 - $446.08 $50,961 - $55,760
125 Added 8.4%
1,613 $674,000
Q4 2023

Feb 07, 2024

BUY
$343.0 - $410.68 $109,417 - $131,006
319 Added 27.29%
1,488 $605,000
Q3 2023

Nov 08, 2023

BUY
$338.18 - $362.46 $47,345 - $50,744
140 Added 13.61%
1,169 $407,000
Q2 2023

Jul 24, 2023

BUY
$314.42 - $351.91 $1,572 - $1,759
5 Added 0.49%
1,029 $362,000
Q1 2023

May 03, 2023

BUY
$283.23 - $323.1 $290,027 - $330,854
1,024 New
1,024 $323,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $127B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Prossimo Advisors, LLC Portfolio

Follow Prossimo Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prossimo Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prossimo Advisors, LLC with notifications on news.